The association between sodium–glucose cotransporter 2 inhibitors and contrast-associated acute kidney injury in patients with type 2 diabetes undergoing angiography: a propensity-matched study

Abstract Background Sodium–glucose cotransporter-2 inhibitors (SGLT2i) have been proven to prevent decline in kidney function and failure. Whether SGLT2i affect the risk of contrast-associated acute kidney injury (CA-AKI) remains uncertain. Methods Use of SGLT2i was assessed in consecutive diabetics...

Full description

Bibliographic Details

Published in:	European Journal of Medical Research
Main Authors:	Hao Yang, Lili Yang, Meg J. Jardine, Clare Arnott, Brendon L. Neuen, Kexi Xu, Xiaohui Zhao, Dehui Qian, Bin Cui, Youzhu Qiu, Yuli Huang, Jie Yu, Jiang Wang, Shiyong Yu, Hu Tan, Lan Huang, Jing-Wei Li, Jun Jin
Format:	Article
Language:	English
Published:	BMC 2024-12-01
Subjects:	Sodium–glucose cotransporter 2 inhibitor Contrast-associated acute kidney injury Diabetes mellitus Coronary angiography Percutaneous coronary intervention
Online Access:	https://doi.org/10.1186/s40001-024-02214-7